The store will not work correctly when cookies are disabled.
5-(4-Cyanophenyl)-1,3,4-oxadiazol-2(3H)-one
ID: ALA4744661
PubChem CID: 64194371
Max Phase: Preclinical
Molecular Formula: C9H5N3O2
Molecular Weight: 187.16
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: N#Cc1ccc(-c2n[nH]c(=O)o2)cc1
Standard InChI: InChI=1S/C9H5N3O2/c10-5-6-1-3-7(4-2-6)8-11-12-9(13)14-8/h1-4H,(H,12,13)
Standard InChI Key: PAPSULCRMMWHDW-UHFFFAOYSA-N
Molfile:
RDKit 2D
14 15 0 0 0 0 0 0 0 0999 V2000
28.3279 -5.1219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3267 -5.9414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0348 -6.3504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7444 -5.9409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7416 -5.1183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0330 -4.7130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0284 -3.8922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6880 -3.4099 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.4332 -2.6334 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.6160 -2.6359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3659 -3.4138 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.1336 -1.9762 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.0375 -7.1635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0373 -7.9807 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 11 1 0
11 7 1 0
6 7 1 0
10 12 2 0
13 14 3 0
3 13 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 187.16 | Molecular Weight (Monoisotopic): 187.0382 | AlogP: 0.90 | #Rotatable Bonds: 1 |
Polar Surface Area: 82.68 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.25 | CX Basic pKa: ┄ | CX LogP: 1.52 | CX LogD: 1.20 |
Aromatic Rings: 2 | Heavy Atoms: 14 | QED Weighted: 0.72 | Np Likeness Score: -1.23 |
References
1. Mahy W,Willis NJ,Zhao Y,Woodward HL,Svensson F,Sipthorp J,Vecchia L,Ruza RR,Hillier J,Kjær S,Frew S,Monaghan A,Bictash M,Salinas PC,Whiting P,Vincent JP,Jones EY,Fish PV. (2020) 5-Phenyl-1,3,4-oxadiazol-2(3H)-ones Are Potent Inhibitors of Notum Carboxylesterase Activity Identified by the Optimization of a Crystallographic Fragment Screening Hit., 63 (21): [PMID:33124429] [10.1021/acs.jmedchem.0c01391] |